SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Rigel Pharmaceuticals Q3 2026 Earnings Call Begins

Rigel Pharmaceuticals' quarterly earnings call has begun.

RIGL
SquawkNews Desk

Rigel Pharmaceuticals's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.

Related stories

Bancorp 34, Inc. Reports 3rd Quarter Performance Third Quarter 2026 HighlightsSCOTTSDALE, AZ / / November 5, 2026 / Bancorp 34, Inc. OTC:BCTF, the parent company for Southwest Heritage Bank, together, the "Company" reports third L impact | EQUITY | Nov 05, 2026, 10:36 PM UTC Maxim Power Announces Third-Quarter 2026 Financial and Operating Results Maxim Power announced the release of its financial and operating results for the quarter ended September 30, 2026. The interim financial statements are unaudited. M impact | EQUITY | Nov 05, 2026, 10:36 PM UTC Mattel Lowers Full-Year Sales and Earnings Guidance After Mixed Results Mattel reported mixed quarterly results and lowered its full-year guidance for sales and earnings. Adjusted earnings were $1.30 a share, above 94 cents a share. The company also na M impact | EQUITY | Nov 05, 2026, 10:36 PM UTC Funko Reports Third-Quarter 2026 Financial Results Funko reported its third-quarter results and reaffirmed previously issued full-year net sales and adjusted EBITDA guidance. M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC VAALCO Energy Reports Q3 2026 Loss, Higher Production and Updated Guidance VAALCO reported a $39.8 million net loss, or $0.38 per diluted share, primarily attributed to non-cash derivative losses. Adjusted EBITDAX rose 30% to $71.1 million, and working-in M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC IBEX Reports Fiscal Q1 Revenue Growth and Raises Full-Year Guidance Revenue rose 16% year over year to $175.2 million, while net income increased to $14.8 million from $12.0 million. IBEX raised its full-year revenue and adjusted EBITDA guidance. M impact | EQUITY | Nov 05, 2026, 10:34 PM UTC